Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma

Clinical trial NCT01972750 · UNKNOWN

Trial details

NCT number: NCT01972750
Sponsor: PD Dr. Martin Glas
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

First or Second Recurrence of Glioblastoma

Start date: 2013-10-01
Primary completion: 2016-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.